Target intelligence / Profile preview

Ionotropic glutamate receptor kainate-type subunit (KAR)

Target
KAR
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Ionotropic glutamate receptor
01

Overview

Ionotropic glutamate receptor kainate-type subunits (KARs) are a distinct family of ligand-gated ion channels that mediate excitatory neurotransmission in the central nervous system. They are composed of five subunits (GluK1-GluK5) that assemble into tetrameric complexes, functioning both as ion channels and through non-canonical metabotropic signaling pathways. KARs play a critical role in modulating synaptic plasticity and regulating the release of other neurotransmitters, such as GABA and glutamate, at both presynaptic and postsynaptic sites. Dysregulation of KAR signaling is strongly implicated in various neurological and psychiatric conditions, including epilepsy, chronic pain, and mood disorders. Consequently, these receptors are significant therapeutic targets, with research focusing on subunit-selective antagonists to treat hyperexcitability-related diseases without the broad side effects associated with other glutamate receptor modulators.

Other names
Kainate receptorGlutamate receptor ionotropic kainateGRIKGluKiGluR5-7KA1-2
02

Mechanism of action

Antagonism of kainate receptors to reduce excitatory neurotransmission; Allosteric modulation to stabilize the desensitized state; Agonism to induce excitotoxicity in experimental models.

03

Biological functions

Signal transductionSynaptic transmissionExcitatory neurotransmissionSynaptic plasticityNeurotransmitter release regulationNeuronal excitability
04

Disease associations

EpilepsyNeuropathic painSchizophreniaAutism spectrum disorderBipolar disorderDepressionNeurodegenerative disease
05

Safety considerations

ExcitotoxicityCognitive impairmentSeizure induction (with agonists)SedationMotor coordination issues
06

Interacting drugs

Topiramate

6 more in the full profile.

07

Biomarkers

GRIK1 genetic polymorphismsGRIK2 gene expression levelsGlutamate levels in cerebrospinal fluid

Beyond the preview

Go deeper on Ionotropic glutamate receptor kainate-type subunit (KAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ionotropic glutamate receptor kainate-type subunit (KAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call